Delivery Order SPE2DB24D3013-SPE2DB25FFQRN
- Not listed
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,718.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for September 15, 2025. This non-set-aside contract represents a competitively awarded delivery order issued under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,580.20 to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, utilizes firm fixed price terms and was competitively awarded without set-aside provisions. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,954.30 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with an ultimate completion date of June 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $5,051.58 delivery order to AmerisourceBergen Drug Corp for COPAXONE 20 mg/ml syringes, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract issued on September 12, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, valued at $1,971.90 with a firm fixed price structure. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.86 to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with a completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a major...
- The Defense Logistics Agency awarded a $2,730.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Copaxone 40 mg/mL syringes. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,368 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQRNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,202.79 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationship supporting military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, including neurological treatments, specialty medications, and medical supplies essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/17/25 |